Alexza Pharma (ALXA) Tops Q1 EPS by 49c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. TSCO
9. BE
10. SPY

Go back to Alexza Pharma (ALXA) Tops Q1 EPS by 49c

Alexza Reports 2015 First Quarter Financial Results

May 6, 2015 4:05 PM EDT

MOUNTAIN VIEW, Calif., May 6, 2015 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today reported financial results for the quarter ended March 31, 2015.  The net loss and the loss from operations for the first quarter were $0.4 million and $13.0 million, respectively, compared to $10.7 million and $8.8 million during the same quarter in 2014, respectively.  At March 31, 2015, Alexza had consolidated cash, cash equivalents, marketable securities, and restricted cash of $23.9 million.

"We continue to focus on ways in which to drive value in Alexza and our validated Staccato® platform, including continuing the development of AZ-002 (Staccato alprazolam) and... More